Resolution of genotypic heterogeneity in prostate tumors using polymerase chain reaction and comparative genomic hybridization on microdissected carcinoma and prostatic intraepithelial neoplasia foci

Cancer Genetics and Cytogenetics

Volumn 137, Issue 1, 2002, Pages 15-22

  Beheshti, Ben ^a,b   Vukovic, Bisera ^a,b   Marrano, Paula ^a   Squire, Jeremy A ^a   Park, Paul C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME MICRODISSECTION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA EXTRACTION; GENE AMPLIFICATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TRISOMY 8;

CARCINOMA; CARCINOMA IN SITU; CHROMOSOME MAPPING; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS;

EID: 0036697795     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00540-X     Document Type: Article

References (51)

1. Haas G.P., Sakr W.A. Epidemiology of prostate cancer. CA Cancer J Clin. 47:1997;273-287.
2. Wullich B., Breitkreuz T., Zwergel T., Unteregger G., Seitz G., Zang K.D. Cytogenetic evidence of intratumoral focal heterogeneity in prostatic carcinomas. Urologia Internationalis. 48:1992;372-377.
3. Micale M.A., Sanford J.S., Powell I.J., Sakr W.A., Wolman S.R. Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma. paraffin FISH vs. metaphase analysis Cancer Genet Cytogenet. 69:1993;7-12.
4. Aihara M., Wheeler T.M., Ohori M., Scardino P.T. Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology. 43:1994;60-66.
5. Macintosh C.A., Stower M., Reid N., Maitland N.J. Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res. 58:1998;23-28.
6. Al-Maghrabi J., Vorobyova L., Chapman W., Jewett M., Zielenska M., Squire J.A. p53 alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma. analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens Mod Pathol. 14:2001;1252-1262.
7. Teixeira M.R., Waehre H., Lothe R.A., Stenwig A.E., Pandis N., Giercksky K.E., Heim S. High frequency of clonal chromosome abnormalities in prostatic neoplasms sampled by prostatectomy or ultrasound-guided needle biopsy. Genes Chromosomes Cancer. 28:2000;211-219.
8. Bastacky S.I., Wojno K.J., Walsh P.C., Carmichael M.J., Epstein J.I. Pathological features of hereditary prostate cancer. J Urol. 153:1995;987-992.
9. Fuijter E.T., Miller G.J., van de Kaa C.A., van Bokhoven A., Bussemakers M.J., Debruyne F.M., Ruiter D.J., Schalken J.A. Molecular analysis of multifocal prostate cancer lesions. J Pathol. 188:1999;271-277.
10. Bostwick D.G., Shan A., Qian J., Darson M., Maihle N.J., Jenkins R.B., Cheng L. Independent origin of multiple foci of prostatic intraepithelial neoplasia. comparison with matched foci or prostate carcinoma Cancer. 183:1998;1995-2002.
11. Zitzelsberger H., Kulka U., Lehmann L., Walch A., Smida J., Aubele M., Lorch T., Hofler H., Bauchinger M., Werner M. Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primed PCR and comparative genomic hybridization. Virchows Arch. 433:1998;297-304.
12. Ausubel F., Brent R., Kingston R., Moore D., Seidman J., Smith J., Sturhl K. Current protocols in molecular biology. 1998;John Wiley & Sons, Inc, New York.
13. Dracopoli N.C. Current protocols in human genetics. 1998;John Wiley & Sons, Inc, New York.
14. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821.
15. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer. 10:1994;231-243.
16. Gustashaw K.M. Chromosome stains. Barch M.J., Knutsen T., Spurbeck J.L. The AGT cytogenetics laboratory manual. 3rd ed:1997;259-324 Lippincott-Raven Publishers, Philadelphia.
17. Al-Maghrabi J., Vorobyova L., Toi A., Chapman W., Zielenska M., Squire J.A. Identification of numerical chromosomal changes detected by interphase FISH in high-grade prostate intraepithelial neoplasia (HPIN) as a predictor of carcinoma. Arch Pathol Lab Med. 126:2001;165-169.
18. Takimoto Y., Shimazui T., Akaza H., Sato N., Noguchi M. Genetic heterogeneity of surgically resected prostate carcinomas and their biopsy specimens is related to their histologic differentiation. Cancer. 91:2001;362-370.
19. Visakorpi T., Kallioniemi A.H., Syvanen A.C., Hyytinen E.R., Karhu R., Tammela T., Isola J.J., Kallioniemi O.P. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res. 55:1995;342-347.
20. Cher M.L., Bova G.S., Moore D.H., Small E.J., Carroll P.R., Pin S.S., Epstein J.I., Isaacs W.B., Jensen R.H. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res. 56:1996;3091-3102.
21. Cher M.L., MacGrogan D., Bookstein R., Brown J.A., Jenkins R.B., Jensen R.H. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer. 11:1994;153-162.
22. El Gedaily A., Bubendorf L., Willi N., Fu W., Richter J., Moch H., Mihatsch M.J., Sauter G., Gasser T.C. Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization. Prostate. 46:2001;184-190.
23. Speicher M.R., du Manoir S., Schrock E., Holtgreve-Grez H., Schoell B., Lengauer C., Cremer T., Ried T. Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification. Hum Genet. 2:1993;1907-1914.
24. Wiltshire R.N., Duray P., Bittner M.L., Visakorpi T., Meltzer P.S., Tuthill R.J., Liotta L.A., Trent J.M. Direct visualization of the clonal progression of primary cutaneous melanoma. application of tissue microdissection and comparative genomic hybridization Cancer Res. 55:1995;3954-3957.
25. Kuukasjarvi T., Tanner M., Pennanen S., Karhu R., Visakorpi T., Isola J. Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization. Genes Chromosomes Cancer. 18:1997;94-101.
26. Aubele M., Mattis A., Zitzelsberger H., Walch A., Kremer M., Welzl G., Hofler H., Werner M. Extensive ductal carcinoma in situ with small foci of invasive ductal carcinoma. evidence of genetic resemblance by CGH Int J Cancer. 85:2000;82-86.
27. Aubele M., Mattis A., Zitzelsberger H., Walch A., Kremer M., Hutzler P., Hofler H., Werner M. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet. 110:1999;94-102.
28. Aubele M., Zitzelsberger H., Schenck U., Walch A., Hofler H., Werner M. Distinct cytogenetic alterations in squamous intraepithelial lesions of the cervix revealed by laser-assisted microdissection and comparative genomic hybridization. Cancer. 84:1998;375-379.
29. Kim S.H., Godfrey T., Jensen R.H. Whole genome amplification and molecular genetic analysis of DNA from paraffin-embedded prostate adenocarcinoma tumor tissue. J Urol. 162:1999;1512-1518.
30. Kim S.-H., Kim M.S., Jensen R.H. Genetic alterations in microdissected prostate cancer cells by comparative genomic hybridization. Prostate Cancer Prostatic Dis. 3:2000;110-114.
31. Verhagen P.C., Zhu X.L. Rohr LR, Cannon-Albright LA, Tavtigian SV, Skolnick MH, Brothman AR. Microdissection, DOP-PCR, and comparative genomic hybridization of paraffin-embedded familial prostate cancers. Cancer Genet Cytogenet. 122:2000;43-48.
32. Prasad M.A., Trybus T.M., Wojno K.J., Macoska J.A. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers. identification of a potential tumor suppressor gene site Genes Chromosomes Cancer. 23:1998;255-262.
33. Wang J.C., Radford D.M., Holt M.S., Helms C., Goate A., Brandt W., Parik M., Phillips N.J., DeSchryver K., Schuh M.E., Fair K.L., Ritter J.H., Marshall P., Donis-Keller H. Sequence-ready contig for the 1.4-cM ductal carcinoma in situ loss of heterozygosity region on chromosome 8p22-p23. Genomics. 60:1999;1-11.
34. Haggman M.J., Wojno K.J., Pearsall C.P., Macoska J.A. Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma. Urology. 50:1997;643-647.
35. Perinchery G., Bukurov N., Nakajima K., Chang J., Hooda M., Oh B.R., Dahiya R. Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer. Int J Oncol. 14:1999;495-500.
36. Macoska J.A., Beheshti B., Rhim J.S., Hukku B., Lehr J., Pienta K.J., Squire J.A. Genetic characterization of immortalized human prostate epithelial cell cultures. Evidence for structural rearrangements of chromosome 8 and i(8q) chromosome formation in primary tumor-derived cells. Cancer Genet Cytogenet. 120:2000;50-57.
37. Virgin J.B., Hurley P.M., Nahhas F.A., Bebchuk K.G., Mohamed A.N., Sakr W.A., Bright R.K., Cher M.L. Isochromosome 8q formation is associated with 8p loss of heterozygosity in a prostate cancer cell line. Prostate. 41:1999;49-57.
38. Alers J.C., Krijtenburg P.J., Rosenberg C., Hop W.C., Verkerk A.M., Schroder F.H., van der Kwast T.H., Bosman F.T., van Dekken H. Interphase cytogenetics of prostatic tumor progression. specific chromosomal abnormalities are involved in metastasis to the bone Lab Invest. 77:1997;437-448.
39. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers. Nature. 396:1998;643-649.
40. Cahill D., Lengauer C., Yu J., Riggins G., Willson J., Markowitz S., Kinzler K., Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature. 392:1998;300-303.
41. Egawa S., Uchida T., Suyama K., Wang C., Ohori M., Irie S., Iwamura M., Koshiba K. Genomic instability of microsatellite repeats in prostate cancer. relationship to clinicopathological variables Cancer Res. 55:1995;2418-2421.
42. Dahiya R., Lee C., McCarville J., Hu W., Kaur G., Deng G. High frequency of genetic instability of microsatellites in human prostatic adenocarcinoma. Int J Cancer. 72:1997;762-767.
43. Pihan G.A., Doxsey S.J. The mitotic machinery as a source of genetic instability in cancer. Semin Cancer Biol. 9:1999;289-302.
44. Pihan G.A., Purohit A., Wallace J., Malhotra R., Liotta L., Doxsey S.J. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res. 61:2001;2212-2219.
45. Beheshti B., Park P.C., Sweet J.M., Trachtenberg J., Jewett M.A.S., Squire J.A. Evidence of chromosomal instability in prostate cancer determined by spectral karyotyping (SKY) and interphase FISH analysis. Neoplasia. 3:2001;62-69.
46. Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., Cunha G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59:1999;5002-5011.
47. Hayward S.W., Rosen M.A., Cunha G.R. Stromal-epithelial interactions in the normal and neoplastic prostate. Br J Urol. 79(Suppl 2):1997;S18-S26.
48. Suzuki H., Freije D., Nusskern D.R., Okami K., Cairns P., Sidransky D., Isaacs W.B., Bova G.S. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res. 58:1998;204-209.
49. Hugel A., Wernert N. Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer. Br J Cancer. 79:1999;551-557.
50. Saric T., Brkanac Z., Troyer D.A., Padalecki S.S., Sarosdy M., Williams K., Abadesco L., Leach R.J., O'Connell P. Genetic pattern of prostate cancer progression. Int J Cancer. 81:1999;219-224.
51. Rohrbach H., Haas C.J., Baretton G.B., Hirschmann A., Diebold J., Behrendt R.P., Lohrs U. Microsatellite instability and loss of heterozygosity in prostatic carcinomas. comparison of primary tumors, and of corresponding recurrences after androgen-deprivation therapy and lymph-node metastases Prostate. 40:1999;20-27.